NILA Requests CMS to Allow Reconsideration of Tier 1 Codes (G0480) PDF File
12/5/2023 NILA and AAB Comment on FDA’s Proposed LDT Rule
11/15/2023 House Passes 1-Year Delay of PAMA Reimbursement Cuts
11/6/2023 NILA Urges Congress to Provide Immediate PAMA Relief
Click here for laboratory-related information and communications from the Centers for Disease Control and Prevention (CDC).
